A negative EPS means a company lost money per share during a reporting period. This metric indicates financial distress unless the company is in a growth phase.
EPS, or earnings per share, divides net income by outstanding shares. A positive EPS shows profit, while a negative EPS signals a loss. For example, if a company loses $1 million with 200,000 shares outstanding, its EPS is -$5.
| Type | Description |
|---|---|
| Trailing EPS | Based on past performance (e.g., last 12 months) |
| Forward EPS | Projected future earnings (used in P/E ratios) |
| Diluted EPS | Accounts for potential new shares (e.g., stock options) |
Companies often report negative EPS during expansion, such as Amazon in the early 2000s. High research costs or market shifts can also cause losses. For instance, Tesla reported negative EPS for years while scaling production.
However, persistent negative EPS may indicate deeper issues. A study by Harvard Business Review found that companies with consistently negative EPS for over three years face higher bankruptcy risks.
Investors often confuse negative EPS with immediate bankruptcy. While risky, some sectors (e.g., biotech) accept short-term losses for long-term gains. For example, Moderna had negative EPS for years before its COVID-19 vaccine success.
Another mistake is ignoring industry context. Airlines typically have lower EPS due to high fuel costs, while software firms may prioritize growth over profits.
Negative EPS can trigger sell-offs, but growth investors may buy shares expecting future profitability. For instance, Netflix's stock dropped after a negative EPS report in 2012 but recovered as subscriber growth resumed.
Analysts often compare negative EPS against revenue trends. If revenue grows despite losses, the company may be on track for recovery. Conversely, declining revenue with negative EPS signals trouble.
I once tracked a startup with negative EPS for 18 months. Its stock price fell 30%, but revenue grew 200% quarterly. The company eventually turned profitable, rewarding patient investors.